mskcc.org2 天
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than ...
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...
mskcc.org5 天
New AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Many Cancers
Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who ...
mskcc.org3 天
About Your Intensity-Modulated Radiation Therapy (IMRT) to Your Prostate
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
mskcc.org10 年
Ghassan K. Abou-Alfa, MD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org2 天
Behfar Ehdaie, MD, MPH
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org3 年
Nancy Y. Lee, MD, FASTRO
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org10 年
Samuel Singer, MD, FACS
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org3 年
A comprehensive cancer benefits solution
Cancer remains the leading driver of healthcare costs for employers, with a significant rise in cases among people under 50. 1, 2 MSK Direct addresses this challenge, helping benefits leaders ...
mskcc.org2 年
Eileen M. O'Reilly, MD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org9 年
Prasad S. Adusumilli, MD, FACS
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org1 年
David H. Abramson, MD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org1 年
Mario M. Leitao, Jr., MD, FACOG, FACS
Research at MSK Our research impact Research topics Core facilities & resources ...